ClinicalTrials.Veeva

Menu
B

Bogan Sleep Consultants, LLC | Columbia, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pitolisant
TAK-861
JZP-258
E2086
FT218
Mazindol
TAK-925
Serdexmethylphenidate
LY3841136
High-Sodium Oxybate

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

10 of 47 total trials

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight (ENLIGHTEN-3)

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and...

Enrolling
Overweight
Sleep Apnea, Obstructive
Drug: Placebo
Drug: Eloralintide

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling
Narcolepsy Type 1
Drug: TAK-861

The primary purpose of this study is to evaluate the optimal doses of E2086 compared to placebo in participants with narcolepsy for reduction of exce...

Enrolling
Narcolepsy
Drug: E2086
Drug: Placebo

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea...

Not yet enrolling
Overweight
Obstructive Sleep Apnoea
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

The objective of this study is to assess the efficacy of the eXciteOSA device amongst a sample of patients with mild OSA. The study is a multi-center...

Active, not recruiting
Sleep Apnea, Obstructive
Device: eXciteOSA

The solution offered by the Genio System to treat OSA patients with CCC using bilateral HGNS has a favorable risk-benefit ratio, as demonstrated by e...

Active, not recruiting
Sleep Apnea, Obstructive
Device: Genio System

This is an interventional, randomized, parallel group, treatment, Phase 3b/4, double blind, 2-arm study to assess the effect of dupilumab compared to...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

The purpose of this revised Phase IIa study is to demonstrate safety of INS018\_055 over 12 weeks in adults with Idiopathic Pulmonary Fibrosis (IPF).

Enrolling
Idiopathic Pulmonary Fibrosis (IPF)
Drug: INS018_055
Drug: Placebo

The objective of this study is to determine the safety and effectiveness of the aerSleep® II device for treatment of moderate to severe Obstructive S...

Active, not recruiting
Sleep Apnea, Obstructive
Apnea, Sleep
Device: aerSleep II

Multi-center, open-label, prospective, randomized clinical trial of the aura6000(R) System for the reduction of apnea and hypopneas in adult patients...

Active, not recruiting
Hypopnea, Sleep
Apnea, Obstructive Sleep
Device: Hypoglossal Nerve Stimulation

Trial sponsors

Takeda logo
Jazz Pharmaceuticals logo
A
N
Apnimed logo
Eisai logo
H
M
N
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems